Acadia Healthcare Company, Inc. (NASDAQ:ACHC) reported Q2 2017 earnings this Afternoon, coming in at $0.66 per share, beating Wall Street’s estimates of $0.65 per Share. Revenue for the quarter came in at $715.90 million missing the streets estimates of $717.38 million
Analyst Coverage For Acadia Healthcare Company, Inc. (NASDAQ:ACHC)
These are 3 Hold Ratings, 8 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is Buy (Score: 2.83) with a consensus target price of $57.82 , a potential (17.45% upside)Recent Insider Trading for Acadia Healthcare Company, Inc. (NASDAQ:ACHC)
- On 7/5/2017 Reeve B. Waud, Director, sold 50,000 with an average share price of $50.04 per share and the total transaction amounting to $2,502,000.00.
- On 6/22/2017 Reeve B. Waud, Director, sold 50,000 with an average share price of $47.51 per share and the total transaction amounting to $2,375,500.00.
- On 6/16/2017 William Grieco, Director, sold 2,000 with an average share price of $45.42 per share and the total transaction amounting to $90,840.00.
- On 6/14/2017 Reeve B. Waud, Director, sold 724,694 with an average share price of $45.53 per share and the total transaction amounting to $32,995,317.82.
- On 6/9/2017 Reeve B. Waud, Director, sold 50,000 with an average share price of $45.09 per share and the total transaction amounting to $2,254,500.00.
- On 5/4/2017 Randall P Goldberg, VP, sold 4,925 with an average share price of $45.18 per share and the total transaction amounting to $222,511.50.
Recent Trading for Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares of Acadia Healthcare Company, Inc. closed the previous trading session at 49.23 down -0.03 -0.06% with 1,283,904 shares trading hands.